PL344573A1 - Novel formulation containing paroxetine - Google Patents
Novel formulation containing paroxetineInfo
- Publication number
- PL344573A1 PL344573A1 PL99344573A PL34457399A PL344573A1 PL 344573 A1 PL344573 A1 PL 344573A1 PL 99344573 A PL99344573 A PL 99344573A PL 34457399 A PL34457399 A PL 34457399A PL 344573 A1 PL344573 A1 PL 344573A1
- Authority
- PL
- Poland
- Prior art keywords
- formulation containing
- novel formulation
- containing paroxetine
- paroxetine
- novel
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Neurology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9810181.9A GB9810181D0 (en) | 1998-05-13 | 1998-05-13 | Novel formulations |
| PCT/GB1999/001520 WO1999058113A2 (en) | 1998-05-13 | 1999-05-13 | Novel formulation containing paroxetine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL344573A1 true PL344573A1 (en) | 2001-11-05 |
Family
ID=10831927
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL99344573A PL344573A1 (en) | 1998-05-13 | 1999-05-13 | Novel formulation containing paroxetine |
Country Status (20)
| Country | Link |
|---|---|
| EP (1) | EP1077682A2 (ja) |
| JP (1) | JP2002514591A (ja) |
| KR (1) | KR20010043574A (ja) |
| CN (1) | CN1308521A (ja) |
| AP (1) | AP2000002019A0 (ja) |
| AU (1) | AU3940999A (ja) |
| BG (1) | BG105010A (ja) |
| BR (1) | BR9910401A (ja) |
| CA (1) | CA2331871A1 (ja) |
| EA (1) | EA200001174A1 (ja) |
| GB (1) | GB9810181D0 (ja) |
| HU (1) | HUP0102064A2 (ja) |
| ID (1) | ID28019A (ja) |
| IL (1) | IL139594A0 (ja) |
| NO (1) | NO20005683L (ja) |
| PL (1) | PL344573A1 (ja) |
| SK (1) | SK17142000A3 (ja) |
| TR (1) | TR200003350T2 (ja) |
| WO (1) | WO1999058113A2 (ja) |
| ZA (1) | ZA200006562B (ja) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0003232D0 (en) * | 2000-02-11 | 2000-04-05 | Smithkline Beecham Plc | Novel composition |
| CA2359812C (en) | 2000-11-20 | 2004-02-10 | The Procter & Gamble Company | Pharmaceutical dosage form with multiple coatings for reduced impact of coating fractures |
| AU2002330771A1 (en) * | 2001-10-22 | 2003-06-10 | Synthon B.V. | N-formyl derivatives of paroxetine |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9325644D0 (en) * | 1993-12-15 | 1994-02-16 | Smithkline Beecham Plc | Novel formulation |
| US5672612A (en) * | 1996-09-09 | 1997-09-30 | Pentech Pharmaceuticals, Inc. | Amorphous paroxetine composition |
| EA002034B1 (ru) * | 1997-01-15 | 2001-12-24 | Смитклайн Бичам Плс | Композиция на основе пароксетина |
| BR9813808A (pt) * | 1997-12-19 | 2002-05-28 | Smithkline Beecham Corp | Processo para produção de comprimidos para dispersão na mordida |
-
1998
- 1998-05-13 GB GBGB9810181.9A patent/GB9810181D0/en not_active Ceased
-
1999
- 1999-05-13 HU HU0102064A patent/HUP0102064A2/hu unknown
- 1999-05-13 CA CA002331871A patent/CA2331871A1/en not_active Abandoned
- 1999-05-13 EA EA200001174A patent/EA200001174A1/ru unknown
- 1999-05-13 CN CN99808325A patent/CN1308521A/zh active Pending
- 1999-05-13 JP JP2000547965A patent/JP2002514591A/ja active Pending
- 1999-05-13 AU AU39409/99A patent/AU3940999A/en not_active Abandoned
- 1999-05-13 ID IDW20002347A patent/ID28019A/id unknown
- 1999-05-13 EP EP99922302A patent/EP1077682A2/en not_active Withdrawn
- 1999-05-13 KR KR1020007012706A patent/KR20010043574A/ko not_active Application Discontinuation
- 1999-05-13 PL PL99344573A patent/PL344573A1/xx unknown
- 1999-05-13 TR TR2000/03350T patent/TR200003350T2/xx unknown
- 1999-05-13 SK SK1714-2000A patent/SK17142000A3/sk unknown
- 1999-05-13 BR BR9910401-6A patent/BR9910401A/pt not_active Application Discontinuation
- 1999-05-13 WO PCT/GB1999/001520 patent/WO1999058113A2/en not_active Application Discontinuation
- 1999-05-13 IL IL13959499A patent/IL139594A0/xx unknown
- 1999-05-13 AP APAP/P/2000/002019A patent/AP2000002019A0/en unknown
-
2000
- 2000-11-10 NO NO20005683A patent/NO20005683L/no not_active Application Discontinuation
- 2000-11-13 ZA ZA200006562A patent/ZA200006562B/en unknown
- 2000-11-30 BG BG105010A patent/BG105010A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ZA200006562B (en) | 2002-02-13 |
| GB9810181D0 (en) | 1998-07-08 |
| HUP0102064A2 (hu) | 2002-05-29 |
| ID28019A (id) | 2001-05-03 |
| WO1999058113A3 (en) | 2000-02-17 |
| NO20005683D0 (no) | 2000-11-10 |
| TR200003350T2 (tr) | 2001-03-21 |
| AP2000002019A0 (en) | 2000-12-31 |
| AU3940999A (en) | 1999-11-29 |
| BR9910401A (pt) | 2001-01-09 |
| WO1999058113A2 (en) | 1999-11-18 |
| NO20005683L (no) | 2000-12-05 |
| EP1077682A2 (en) | 2001-02-28 |
| SK17142000A3 (sk) | 2001-06-11 |
| EA200001174A1 (ru) | 2001-06-25 |
| IL139594A0 (en) | 2002-02-10 |
| CN1308521A (zh) | 2001-08-15 |
| CA2331871A1 (en) | 1999-11-18 |
| BG105010A (en) | 2001-07-31 |
| KR20010043574A (ko) | 2001-05-25 |
| JP2002514591A (ja) | 2002-05-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL341372A1 (en) | Cellecoxibe containing compositions | |
| EP1016400A4 (en) | COMPOSITION FOR EXTERNAL USE | |
| PT1466615E (pt) | Composição farmacêutica | |
| GB9809058D0 (en) | Composition | |
| PL343769A1 (en) | Pharmaceutical composition | |
| GB9818591D0 (en) | Pharmaceutical composition | |
| GB9812119D0 (en) | Composition | |
| PL334568A1 (en) | Paroxetin containing compositions | |
| GB9806788D0 (en) | Composition | |
| IL142534A0 (en) | Pharmaceutical compositions containing an antigen-adjuvent | |
| IL136106A0 (en) | Formulations comprising dissolved paroxetine | |
| GB9806793D0 (en) | Composition | |
| HUP0101931A3 (en) | Novel formulation containing paroxetine | |
| HK1044117B (zh) | 藥物組合物 | |
| PL343095A1 (en) | Paroxetine compositions | |
| PL344137A1 (en) | Novel composition | |
| GB2331703B (en) | Disinfectant compositions | |
| PL344573A1 (en) | Novel formulation containing paroxetine | |
| GB9804041D0 (en) | Composition | |
| GB9904523D0 (en) | Platinum (11) compounds | |
| HU9800078D0 (en) | Pharmaceutical composition | |
| GB9806791D0 (en) | Composition | |
| GB9818910D0 (en) | Novel formulation | |
| GB9818905D0 (en) | Novel formulation | |
| GB9803982D0 (en) | Composition |